Vivanza Biosciences Formalizes MOA Amendment for Packaging Business Expansion

Vivanza Biosciences Limited has officially notified BSE Limited about the approved amendment to its Memorandum of Association (MOA) for business expansion into plastic polymer films and packaging materials manufacturing. The company submitted the formal intimation on December 18, 2025, under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory Notification Details

Managing Director Jayendra Mehta (DIN: 08210602) formally communicated the MOA alteration to BSE, confirming that shareholders have approved the insertion of a new sub-clause 7 after the existing sub-clause 6 of Clause III(A). The notification follows the company's successful postal ballot results announced on December 17, 2025:

Voting Results:	Details
Total Votes Cast:	51,11,639
Votes in Favor:	51,06,561 (99.90%)
Votes Against:	4,978 (0.10%)
Shareholder Approval:	Overwhelming support

Comprehensive Business Scope

The approved MOA amendment provides detailed specifications for the company's new business activities. The expanded scope includes manufacturing plastic polymer films of 25 microns thickness, plastic bags and sacks made from polyethylene (PE) and polypropylene (PP), and paper bags for packaging with or without plastic coating or lamination:

Business Activities:	Scope
Manufacturing:	Plastic polymer films, PE/PP bags, paper bags
Target Markets:	Food, chemicals, fertilizers, grains, consumer goods
Operations:	Domestic and international trade, supply, distribution
Infrastructure:	Manufacturing units, warehouses, distribution centers
R&D Focus:	Product improvement and innovation

Regulatory Compliance Framework

The amendment is subject to necessary approvals from the Ministry of Corporate Affairs, Stock Exchanges, and other regulatory authorities as applicable. The company has outlined comprehensive operational capabilities including procurement and import of raw materials, research and development activities, and obtaining necessary patents, licenses, and regulatory approvals.

Strategic Transformation

The formal notification confirms Vivanza Biosciences' strategic shift from a pure biosciences operation to a diversified manufacturing entity. The 99.90% shareholder approval demonstrates exceptional investor confidence in the company's expansion strategy into the growing packaging industry, potentially opening significant new revenue streams across multiple industrial and consumer applications.

Implementation Timeline

With the postal ballot process completed and regulatory notification submitted, the company can now proceed with implementing its diversification plans. The voting process, conducted by scrutinizer CS Chintan K. Patel and managed through Purva Sharegistry (India) Private Limited's e-voting platform, ensures full compliance with Section 110 of the Companies Act, 2013.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+3.37%	+5.91%	-8.51%	-0.92%	-33.64%	-80.45%

Vivanza Biosciences Limited , a company listed on the BSE, has announced several key developments in its recent board meeting held on November 11, 2025. The company has reported its quarterly results, made changes in key personnel, and proposed a significant alteration to its business objectives.

Financial Performance

The board of Vivanza Biosciences approved the unaudited financial results for the quarter ended September 30, 2025. The company reported:

Particulars	Amount (in Rs. lacs)
Revenue from Operations	373.18
Profit Before Tax	48.06

These figures demonstrate the company's operational performance for the quarter, providing investors with insights into its financial health.

Changes in Key Personnel

New Company Secretary Appointment

The board, on recommendations from the Nomination and Remuneration Committee, has approved the appointment of CS Chaitra Arora as the new Company Secretary and Compliance Officer. CS Arora, holding membership number A78376, will take on this key managerial role effective November 11, 2025.

CS Arora brings experience in company law, SEBI regulations, and IPO due diligence to her new position. Her skills in drafting and practical knowledge of corporate governance, compliance, and regulatory filings are expected to be valuable assets to the company.

Previous Company Secretary's Resignation

This appointment follows the resignation of CS Siddhi Shah (Membership number A44885) from the position of Company Secretary & Compliance Officer. CS Shah's resignation, effective from September 26, 2025, was attributed to personal reasons and career advancement opportunities.

Proposed Business Expansion

The board has approved an alteration to the company's main object clause in its Memorandum of Association (MOA). This proposed change aims to expand Vivanza Biosciences' business scope to include:

Manufacturing, processing, producing, and dealing in plastic polymer films
Production of plastic bags and sacks from various polymers
Manufacturing paper bags for packaging
Developing flexible packaging materials for diverse applications

This expansion, if approved by shareholders, would mark a strategic diversification for the company, potentially opening up new revenue streams in the packaging industry.

Shareholder Approval Process

The company has initiated a postal ballot process to seek shareholder approval for the proposed alteration in the MOA. Key dates for this process include:

Cut-off date for shareholder eligibility: November 7, 2025
E-voting period: November 17, 2025 (9:00 AM) to December 16, 2025 (5:00 PM)
Results declaration: By December 18, 2025

Mr. Chintan K. Patel, a Practicing Company Secretary, has been appointed as the scrutinizer for the e-voting process.

These developments indicate that Vivanza Biosciences is taking steps to strengthen its corporate governance and explore new business opportunities. Shareholders and potential investors should closely monitor these changes and their potential impact on the company's future performance and market position.